These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16382538)

  • 1. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor.
    Frucht SJ; Houghton WC; Bordelon Y; Greene PE; Louis ED
    Neurology; 2005 Dec; 65(12):1967-9. PubMed ID: 16382538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders.
    Frucht SJ; Bordelon Y; Houghton WH; Reardan D
    Mov Disord; 2005 Oct; 20(10):1330-7. PubMed ID: 15986420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ; Perkins AT; Michalek JE;
    Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
    Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonisamide for essential tremor: an evaluator-blinded study.
    Handforth A; Martin FC; Kang GA; Vanek Z
    Mov Disord; 2009 Feb; 24(3):437-40. PubMed ID: 19117357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked amelioration of alcohol-responsive posthypoxic myoclonus by gamma-hydroxybutyric acid (Xyrem).
    Frucht SJ; Bordelon Y; Houghton WH
    Mov Disord; 2005 Jun; 20(6):745-51. PubMed ID: 15751049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol-Responsive Hyperkinetic Movement Disorders-a Mechanistic Hypothesis.
    Frucht SJ; Riboldi GM
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():47. PubMed ID: 33178485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of alcohol on gait in patients with essential tremor.
    Klebe S; Stolze H; Grensing K; Volkmann J; Wenzelburger R; Deuschl G
    Neurology; 2005 Jul; 65(1):96-101. PubMed ID: 16009892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorders and alcohol misuse.
    Hess CW; Saunders-Pullman R
    Addict Biol; 2006 Jun; 11(2):117-25. PubMed ID: 16800824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of levetiracetam on essential tremor.
    Bushara KO; Malik T; Exconde RE
    Neurology; 2005 Mar; 64(6):1078-80. PubMed ID: 15781835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.
    Lorenz D; Hagen K; Ufer M; Cascorbi I; Deuschl G; Volkmann J
    Neurology; 2006 Jun; 66(11):1753-5. PubMed ID: 16769957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ethanol on the central oscillator in essential tremor.
    Zeuner KE; Molloy FM; Shoge RO; Goldstein SR; Wesley R; Hallett M
    Mov Disord; 2003 Nov; 18(11):1280-5. PubMed ID: 14639668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid occurrence of depression following addition of sodium oxybate to modafinil.
    Rossetti AO; Heinzer RC; Tafti M; Buclin T
    Sleep Med; 2010 May; 11(5):500-1. PubMed ID: 20133191
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.
    Morita S; Miwa H; Kondo T
    Parkinsonism Relat Disord; 2005 Mar; 11(2):101-3. PubMed ID: 15734668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.